JP2025504481A5 - - Google Patents

Info

Publication number
JP2025504481A5
JP2025504481A5 JP2024543162A JP2024543162A JP2025504481A5 JP 2025504481 A5 JP2025504481 A5 JP 2025504481A5 JP 2024543162 A JP2024543162 A JP 2024543162A JP 2024543162 A JP2024543162 A JP 2024543162A JP 2025504481 A5 JP2025504481 A5 JP 2025504481A5
Authority
JP
Japan
Prior art keywords
agent
binds
pathogen
immunoglobulin
linker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024543162A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025504481A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/060893 external-priority patent/WO2023141500A2/en
Publication of JP2025504481A publication Critical patent/JP2025504481A/ja
Publication of JP2025504481A5 publication Critical patent/JP2025504481A5/ja
Pending legal-status Critical Current

Links

JP2024543162A 2022-01-19 2023-01-19 ナノボディ－薬物付加物およびその使用 Pending JP2025504481A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263300995P 2022-01-19 2022-01-19
US63/300,995 2022-01-19
US202263423667P 2022-11-08 2022-11-08
US63/423,667 2022-11-08
PCT/US2023/060893 WO2023141500A2 (en) 2022-01-19 2023-01-19 Nanobody-drug adducts and uses thereof

Publications (2)

Publication Number Publication Date
JP2025504481A JP2025504481A (ja) 2025-02-12
JP2025504481A5 true JP2025504481A5 (https=) 2026-01-27

Family

ID=87349125

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024543162A Pending JP2025504481A (ja) 2022-01-19 2023-01-19 ナノボディ－薬物付加物およびその使用

Country Status (8)

Country Link
US (1) US20250144228A1 (https=)
EP (1) EP4466292A2 (https=)
JP (1) JP2025504481A (https=)
KR (1) KR20240134971A (https=)
AU (1) AU2023209439A1 (https=)
CA (1) CA3249160A1 (https=)
IL (1) IL314208A (https=)
WO (1) WO2023141500A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025081106A2 (en) * 2023-10-12 2025-04-17 Vanderbilt University Nanobody vaccine compositions
WO2025085675A1 (en) * 2023-10-17 2025-04-24 Mary Lynn Niedrauer Conjugates, compositions and methods for treating rsv infection
WO2026011056A1 (en) 2024-07-02 2026-01-08 Cerberus Therapeutics Compositions and methods for improving immune response

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9751945B2 (en) * 2012-04-13 2017-09-05 Whitehead Institute For Biomedical Research Sortase-modified VHH domains and uses thereof
EP4157883A4 (en) * 2020-06-02 2024-12-04 Children's Medical Center Corporation NANOBODY CONJUGATES (VHH) AND THEIR USES

Similar Documents

Publication Publication Date Title
JP2025504481A5 (https=)
JP2024026876A5 (https=)
CN113316591A (zh) Cd73抗体及其制备方法和应用
JP2022068302A5 (https=)
JP2022028828A5 (https=)
JP2021185136A5 (https=)
CN115605510A (zh) B7h3抗体-依喜替康类似物偶联物及其医药用途
WO2008088658A3 (en) Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites
JP2021038271A5 (https=)
JP2023100643A5 (https=)
JP2024016014A5 (https=)
JP2022060295A5 (https=)
JP2014534467A5 (https=)
WO2025083071A3 (en) Antibody-drug conjugates
JP2024112817A5 (https=)
JP2011519947A5 (https=)
CN115427453A (zh) Cldn18.2抗体及其用途
JP2020171301A5 (https=)
MX2021007706A (es) Conjugados de agonistas de receptor de reconocimiento de patron.
MX2025002793A (es) Conjugado de anticuerpo y farmaco que comprende un inhibidor de nmt y sus usos
JP2023011759A5 (https=)
JP2024063214A5 (https=)
JP2022544380A5 (https=)
WO2022194988A3 (en) B-lymphocyte specific amatoxin antibody conjugates
JP2020141705A5 (https=)